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THE MORAL INTERCEPTION OF ORAL
CONTRACEPTION: POTENTIAL
CONSTITUTIONAL CLAIMS AGAINST THE
FDA’S PRESCRIPTION REQUIREMENT FOR
A PROGESTIN-ONLY BIRTH CONTROL PILL
Scout Richters*
INTRODUCTION
In its July/August 2012 issue, The Atlantic magazine named an
over-the-counter birth control pill one of the “Biggest Ideas of the
Year.”1 In actuality, the idea of making an oral contraceptive
available over the counter is far from novel.2 In 1993, The
American Journal of Public Health published an editorial asserting
“safety and compliance concerns are no longer sufficient to justify
maintaining the current clinical control over a woman’s
contraceptive selection.”3 The editorial went on to declare that “[a]
national dialogue on [the issue of over-the-counter oral
contraceptives] is overdue.”4 Twenty years later, the unavailability
of a daily over-the-counter oral contraceptive has the growing
* J.D. Candidate, Brooklyn Law School, 2014; B.J., University of NebraskaLincoln, 2011. I would like to thank my family and friends, especially Tex
Richters, Judy Garlock, and Kelsey Richters, for their encouragement and
reassurance. I would also like to thank the Journal of Law and Policy staff for
all of their help in preparing the note for publication.
1
The
Ideas
Report,
ATLANTIC
(July
2012),
http://www.theatlantic.com/special-report/ideas-2012/; Nicole Allan, Sell
the
Pill
Over
the
Counter,
ATLANTIC
(June
13,
2012),
http://www.theatlantic.com/magazine/archive/2012/07/sell-the-pill-over-thecounter/308997/.
2
See, e.g., James Trussell et al., Should Oral Contraceptives Be Available
Without Prescription?, 83 AM. J. PUB. HEALTH 1094 (1993).
3
Id.
4
Id.
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potential to generate a meritorious constitutional claim implicating
the right to privacy and embedded right to use contraception.
While the idea of an over-the-counter birth control pill is not
new, there has undoubtedly been a recent resurgence in the
movement for such a contraceptive option.5 For example, in a 2012
Committee Opinion, the American College of Obstetricians and
Gynecologists (ACOG), the largest association of OB/GYNs in the
country, announced its support for the sale of over-the-counter oral
contraceptives.6 The American Medical Association (AMA)
followed suit.7 During its 2013 annual meeting, the AMA adopted
a resolution recommending “that manufacturers of oral
contraceptives be encouraged to submit the required application
and supporting evidence for the [Food and Drug Administration
(FDA)] to consider approving a switch in status from prescription
to over-the-counter for such products . . . .”8
Additionally, recent cases such as Tummino v. Von
5

See, e.g., Margaret Wente, Drop the Paternalism and Sell the
Pill over the Counter, GLOBE & MAIL (Mar. 20, 2012, 2:00 AM),
http://www.theglobeandmail.com/commentary/drop-the-paternalism-and-sellthe-pill-over-the-counter/article536144/. FDA-approved birth control methods
can be divided into several classes. FDA, OFFICE OF WOMEN’S HEALTH, Birth
Control Guide, available at http://www.fda.gov/downloads/ForConsumers/
ByAudience/ForWomen/FreePublications/UCM356451.pdf (listing various
kinds of oral contraception and how they are used). These classes include
“Barrier Methods,” “Hormonal Methods,” “Emergency Contraception,”
“Implanted Devices,” and “Permanent Methods.” A daily birth control pill is a
hormonal method of contraception. Both the estrogen-progestin combination
oral contraceptive as well as the progestin-only variety are currently FDAapproved but are available only with a doctor’s prescription. Id.
6
AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, COMM. ON
GYNECOLOGIC PRACTICE, COMM. OP. NO. 544, OVER-THE-COUNTER ACCESS TO
ORAL CONTRACEPTIVES 1–3 (2012), available at http://www.acog.org/~/
media/Committee%20Opinions/Committee%20on%20Gynecologic%20Practice
/co544.pdf. See also Abby Ohlheiser, OB/GYNs Back Over-The-Counter Birth
Control, SLATE (Nov. 21, 2012, 11:00 AM), http://www.slate.com/blogs/
the_slatest/2012/11/21/over_the_counter_birth_control_backed_by_largest_ob_
gyn_group_in_the_country.html.
7
Annual Meeting Memorial Resolutions, Am. Med. Ass’n (June 2013), at
464 [hereinafter AMA Resolutions], available at http://www.amaassn.org/assets/meeting/2013a/a13-resolutions.pdf.
8
Id.
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Eschenbach9 and Tummino v. Hamburg10 suggest that the current
movement for expanded contraceptive access has made its way to
the courts. In Hamburg, plaintiffs initially brought action in 2005
challenging the FDA’s decision to deny a citizen petition11
requesting that all women, regardless of age, have over-the-counter
access to emergency contraception.12 Judge Edward R. Korman
presided over the Hamburg case. He found that the FDA’s denial
of the citizen petition for over-the-counter emergency
contraception rested on unusual actions, deviations from policy,
and the unprecedented involvement of the Health and Human
Services (HHS) Secretary Kathleen Sebelius.13
Judge Korman ultimately instructed the FDA to “make
levonorgestrel-based emergency contraceptives14 available [to
9

Tummino v. Von Eschenbach, 427 F. Supp. 2d 212 (E.D.N.Y. 2006).
Tummino v. Hamburg, 936 F. Supp. 2d 162 (E.D.N.Y. 2013).
11
A citizen petition can be filed with the FDA requesting that the Agency
“issue, amend, or revoke a regulation or order or take or refrain from taking any
other form of administrative action.” 21 C.F.R. § 10.25 (2010). “A Citizen
Petition may be filed at anytime” and “must contain certain things such as
clearly stating what the Petitioner is asking the FDA to do and a statement of
grounds for the request. After the Petition is filed, anyone can file comments
about it, and the Dockets Management Branch will then send the Petition and
any comments to the appropriate divisions within FDA for resolution.” The
Petition Process, FDA PETITIONS, http://www.fdapetitions.com/process.html
(last visited Nov. 2, 2013).
12
Hamburg, 936 F. Supp. 2d at 165. See also 21 C.F.R. § 310.200(b)
(2010) (“A proposal to exempt a drug from the prescription-dispensing
requirement of section 503(b)(1)(C) of the act may be initiated by the
Commissioner or by any interested person. Any interested person may file a
[Citizen] [P]etition seeking such exemption . . . .”). “Emergency contraception,
or emergency birth control, is used to help keep a woman from getting
pregnant after she has had sex without using birth control or if the birth control
method failed.” Emergency Contraception (Emergency Birth Control) Fact
Sheet,
OFFICE
ON
WOMEN’S
HEALTH,
http://www.womenshealth
.gov/publications/our-publications/fact-sheet/emergency-contraception.cfm#a
(last updated Nov. 2, 2011).
13
Hamburg, 936 F. Supp. 2d at 169–71.
14
Levonorgestrel “is a progestin hormone that prevents pregnancy by
preventing the release of an egg (ovulation) and changing the womb and cervical
mucus to make it more difficult for an egg to meet sperm (fertilization) or attach
to the wall of the womb (implantation).” Levonorgestrel Oral, WEBMD,
http://www.webmd.com/drugs/drug-17833-levonorgestrel+oral.aspx (last visited
10
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women of all ages] without a prescription . . . .”15 Judge Korman
further stated that the FDA did not have the authority to require
that Plan B16 “be sold only at pharmacies and health clinics and
that it be kept behind the counter” as had been its practice.17 This,
he held, constituted an impermissible point-of-sale restriction on
the distribution of emergency contraception.18 Though the decision
to ban age and point-of-sale restrictions on the sale of Plan B
concerned emergency contraception rather than a daily birth
control pill (“the pill” or “birth control pill”), it indicates the
potential for judicial involvement in the FDA’s future decisions
concerning contraceptive access.
While there is strong support for expanded access to
contraception, there are staunch opponents to an over-the-counter
daily birth control pill.19 The Catholic Medical Association, for
example, ardently opposes the ACOG’s recommendation to make
birth control pills available over the counter.20 Catholic
obstetricians and gynecologists (OB/GYNs) largely cite safety
concerns as their reason for opposition, although one St. Louis
OB/GYN, Dr. Richard Brennan, reasoned that “[e]asier access to
the pill means more people taking the pill, and in turn, a higher
number of contraceptive failure. As we know, greater than [fifty]
percent of abortions today are a result of contraceptive failures.”21
Opponents also have financial reasons to oppose an over-thecounter birth control pill.22 For example, since pap smears are now
Nov. 2, 2013).
15
Hamburg, 936 F. Supp. 2d at 197.
16
Plan B is a brand of emergency contraception. About, PLAN B ONE-STEP,
http://www.planbonestep.com/about-plan-b-one-step.aspx (last visited Nov. 3,
2013).
17
Hamburg, 936 F. Supp. 2d at 180, 183.
18
Id. at 183.
19
See, e.g., Jennifer Brinker, Easier Access? Statement Pushing Over-theCounter Access to the Pill Leaves Some Wondering How it Truly Benefits
Women, ST. LOUIS REV. (Dec. 19, 2012), http://stlouisreview.com/
article/2012-12-19/easier-access.
20
Id.
21
Id.
22
See Elisabeth Rosenthal, Is It Time for Off-the-Shelf Birth-Control Pills?,
N.Y. TIMES (Apr. 20, 2013), http://www.nytimes.com/2013/04/21/sundayreview/is-it-time-for-off-the-shelf-birth-control-pills.html (discussing arguments
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recommended once every three years, many young women see
their gynecologists every year just to obtain birth-control
prescriptions.23 Therefore, if women could obtain the pill over the
counter, they would visit their gynecologists less frequently,
resulting in a financial loss for the gynecologist.24 Moreover,
whether it be to curry favor with constituents like the religious
groups and medical professionals described above, or to simply
make their own views public, some politicians have recently
expressed opposition to expanded access to birth control.25
Therefore, certain medical professionals, religious groups, and
politicians oppose an over-the-counter pill for a myriad of reasons.
Though reproductive rights advocates or other interested
parties have not yet submitted a citizen petition requesting that a
daily birth control pill be switched from prescription to over-thecounter status,26 proponents of such a switch have initiated a
dialogue with the FDA.27 For example, on March 23, 2012, the
FDA held a public hearing entitled, Using Innovative Technologies
and other Conditions of Safe Use to Expand Which Drug Products
Can Be Considered Nonprescription.28 At the hearing, several
presenters urged FDA panelists to consider making a daily
hormonal birth control pill available without a prescription.29
Daniel Grossman, Assistant Clinical Professor of Obstetrics and
Gynecology at the University of California at San Francisco,
that drug companies and gynecologists could lose business as a result of women
gaining easier access to birth-control pills).
23
Id.
24
Id.
25
See, e.g., Nick Baumann, The Republican War on Contraception,
MOTHER JONES (Feb. 9, 2012), http://www.motherjones.com/politics/2012/02/
republican-war-birth-control-contraception.
26
See, e.g., AMA Resolutions, supra note 7, at 464 (recommending that an
equivalent manufacturer’s application be filed).
27
See FOOD & DRUG ADMIN., CTR. FOR DRUG EVALUATION & RES., FDA2012-N-0171, USING INNOVATIVE TECHNOLOGIES AND OTHER CONDITIONS OF
SAFE USE TO EXPAND WHICH DRUG PRODUCTS CAN BE CONSIDERED
NONPRESCRIPTION 7, 37 (2012) [hereinafter FDA Public Hearing
2012],
available
at
http://www.fda.gov/downloads/Drugs/NewsEvents/
UCM301940.pdf.
28
Id at 1.
29
See id. at 38–52.
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presented at the hearing.30 During his presentation, Grossman told
panelists that despite the safety and popularity of oral
contraceptives, the high rate of unintended pregnancies indicates
that the prescription requirement may impose a significant barrier
to access for some women.31
According to Grossman and other proponents of an over-thecounter birth control pill, a progestin-only32 oral contraceptive
would be the most likely candidate for initial over-the-counter
availability.33 Because progestin-only oral contraceptives do not
contain estrogen, these birth control pills have fewer
contraindications than their estrogen-progestin combination
counterparts.34 Despite the safety of progestin-only oral
contraceptives, the FDA, as evidenced by its treatment of
emergency contraception, is unlikely to hurry to make a daily
hormonal birth control pill available over the counter. Deviations
from policy, including “intolerable delays,” surrounded the FDA’s
actions with respect to the petition for unrestricted access to over-

30

Id. at 41. Grossman also serves as the coordinator of the Oral
Contraceptives Over-the-Counter Working Group, a privately funded coalition
of scientists, doctors, and reproductive justice advocates who are currently in the
process of evaluating the viability of an over-the-counter oral contraceptive. Id.
at 41–42.
31
Id.
32
A progestin-only oral contraceptive is sometimes called the “mini-pill”
because, unlike combination pills that contain estrogen and progestin, the minipill contains only progestin. Progestin-Only Contraceptives, FAMILY DOCTOR,
http://familydoctor.org/familydoctor/en/prevention-wellness/sex-birthcontrol/birth-control/progestin-only-contraceptives.html (last visited Oct. 18,
2013). “The Mini-Pill affects the mucus around the cervix and makes it harder
for sperm to enter the uterus. It also affects the transport of the egg through the
fallopian tubes. In these ways, the Mini-Pill prevents fertilization.” Mini-Pills,
FEMINIST WOMEN’S HEALTH CTR., http://www.feministcenter.org/healthwellness-services/comprehensive-gyn/birth-control-options/birth-controlinformation/101-mini-pills (last visited Oct. 17, 2013).
33
See Progestin-Only Pill Eyed as OTC OC Candidate, 33
CONTRACEPTIVE TECH. UPDATE 52, 52 (2012).
34
Progestin-Only Contraceptives, supra note 32. A contraindication is a
patient condition that makes a medication unadvisable for use. Definition of
Contraindication, MEDTERMS, http://www.medterms.com/script/main/art.asp?
articlekey=17824 (last visited Oct. 18, 2013).
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the-counter emergency contraception.35 Further, there was
unprecedented involvement by the Secretary of Health and Human
Services that marked the “first time a cabinet member had ever
publicly countermanded a determination by the F.D.A. . . .”36
After the FDA initially agreed to approve an application from Plan
B’s manufacturer to make the product available over the counter
without age restrictions, the HHS Secretary ordered the FDA
Commissioner to deny the application.37 Though the Secretary’s
“political interference”38 applied to the manufacturer’s application
and not the pending citizen petition, her directive “made it
impossible as a practical matter for the FDA to approve the Citizen
Petition” that relied on the same data as the manufacturer’s
application.39 Though the FDA won’t likely replicate these
deviations from policy to delay a hypothetical citizen petition for a
daily over-the-counter oral contraceptive, given its history with
emergency contraception, it is unlikely that the FDA will decide to
initiate actions to make a daily birth control pill available over the
counter.
The FDA has not yet been compelled to make a decision or
take action with regard to an over-the-counter daily birth control
pill because advocates have yet to submit a petition or application.
Without a final agency action sufficient to subject the decision to
judicial review, plaintiffs are unable to bring a constitutional claim.
However, should the FDA take official action and deny an overthe-counter daily birth control pill, then a substantive due process
or equal protection claim challenging the constitutionality of the
prescription requirement would be possible. The constitutionally
recognized right to contraception and the value placed on gender
equality in American society bolster the viability of such a claim.
Additionally, the safety of the progestin-only pill, the availability
of new technology to dispense medicines over the counter, and
mounting public policy considerations serve as practical
justifications for the elimination of the prescription requirement.
35
36
37
38
39

Tummino v. Hamburg, 936 F. Supp. 2d 162, 198 (E.D.N.Y. 2013).
Id. at 170.
Id. at 167.
Id. at 170.
Id. at 169.
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The FDA’s maintenance of the prescription requirement for a
progestin-only birth control pill has the potential to generate a
meritorious substantive due process or equal protection violation
claim. Part I of this Note examines the prevalence of unintended
pregnancies in the United States, discusses the ways in which the
prescription requirement acts as a barrier to contraceptive access
for some women, and finally suggests that, based on the
availability of new technology, a progestin-only pill is safe for
over-the-counter sale. Part II discusses the FDA and the criteria the
Agency uses to switch a medication from prescription to over-thecounter status. Part III assumes arguendo that the FDA’s
maintenance of the prescription requirement would be subject to
judicial review and assesses the viability of a substantive due
process violation claim and an equal protection violation claim
challenging the prescription requirement for a progestin-only pill.
I. UNINTENDED PREGNANCY, BARRIERS
SAFETY OF THE PILL

TO

ACCESS,

AND

THE

A. Prevalence of Unintended Pregnancies in the United States
Nearly half of all pregnancies in the United States are
unintended.40 Whether unwanted or mistimed, minority women,
young women, and low-income women have the highest rates of
these unintended pregnancies.41 While a significant number of
unintended pregnancies end in abortion, many do not.42 Births
from unwanted pregnancies can be problematic for the child, the

40

Facts on Unintended Pregnancy in the United States, FACT SHEET
(Guttmacher Inst., New York, N.Y.), Oct. 2013, at 1, 1–2 [hereinafter Facts on
Unintended Pregnancy], available at http://www.guttmacher.org/pubs/FBUnintended-Pregnancy-US.pdf.
41
Id. at 1.
42
Facts on Induced Abortion in the United States, IN BRIEF (Guttmacher
Inst., New York, N.Y.), Oct. 2013, at 1, 1 [hereinafter Facts on Induced
Abortion], available at http://www.guttmacher.org/pubs/fb_induced_abortion
.pdf (“[A]bout four in [ten]” unintended pregnancies “are terminated by abortion
. . . . Twenty-two percent of all pregnancies (excluding miscarriages) end in
abortion.”).
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mother, and society at large.43
Unintended pregnancies often produce negative consequences
for both the mother and the child. Women who experience
unintended pregnancies and choose to give birth are less likely to
breastfeed, less likely to receive timely prenatal care, and are more
likely to smoke during their pregnancies.44 Substantial research
indicates that women who experience unplanned pregnancies are
more likely than women who planned their pregnancies to
experience depression and other mental health problems both
during their pregnancies and after giving birth.45 In addition,
“unintended births have implications for the child that last from
early childhood through adolescence and even into adulthood.”46
For example, children born as a result of an unintended pregnancy
“have poorer physical health than those whose births were
intended,” may be “less successful in school,” and, according to
one study, are at an increased risk of child abuse.47 Studies also
indicate that the majority of teen pregnancies are unintended.48
“Daughters of teen mothers are three times more likely to become
teen parents themselves than girls born to older moms.”49
Moreover, “sons born to young teens are significantly more likely
to be incarcerated.”50
43

See Jennifer McIntosh et al., Changing Oral Contraceptives from
Prescription to Over-the-Counter Status: An Opinion Statement of the Women’s
Health Practice and Research Network of the American College of Clinical
Pharmacy, 31 PHARMACOTHERAPY 424, 424 (2011).
44
William D. Mosher et al., Intended and Unintended Births in the United
States: 1982–2010, NAT’L HEALTH STATS. REPS., no. 55, July 24, 2012, at 1, 13.
45
Cassandra Logan et al., The Consequences of Unintended Childbearing:
A White Paper, CHILD TRENDS, INC., May 2007, at 8, available at
http://www.thenationalcampaign.org/resources/pdf/consequences.pdf.
46
Id. at 5.
47
Id. at 6, 7.
48
See Lawrence B. Finer & Mia R. Zolna, Unintended Pregnancy in the
United States: Incidence and Disparities, 2006, 84 CONTRACEPTION 478, 481
(2011).
49
Kari Huus, A Baby Changes Everything: The True Cost of Teen
Pregnancy’s
Uptick,
NBC
NEWS
(Feb.
19,
2010),
http://www.nbcnews.com/id/35448556/ns/us_news-the_elkhart_project/t/babychanges-everything-true-cost-teen-pregnancys-uptick.
50
Id.
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Apart from the negative consequences for mothers and
children, unplanned pregnancies result in economic costs to the
public.51 In 2006, public funds totaling more than $11 billion paid
the medical expenses for more than two-thirds of the births
resulting from unintended pregnancies.52 In 2008, the cost of each
birth paid for by Medicaid averaged $12,613, while the
contraceptive costs for each patient would have averaged only
$257.53 Therefore, every dollar invested in contraceptives saves
$3.74 in Medicaid expenses.54 One study evaluated the short-term
monetary public savings of unintended pregnancy prevention
through California’s Medicaid family planning project.55 The
authors estimated that by averting approximately 205,000
unintended pregnancies, the public saved more than $1 billion
within the two years following the prevented pregnancies.56
Additionally, eliminating the prescription requirement for oral
contraceptives would save money on unnecessary medical care.
The IMS Institute for Healthcare Informatics estimates that more
than $200 billion was spent on unnecessary health services in
2009.57 Incidentally, a blood pressure screening and a breast exam
are the “only physical examination steps pertinent to
contraindications of oral contraceptives.”58 Because high blood
pressure is only a contraindication for the estrogen-progestin

51

McIntosh et al., supra note 43.
See Adam Sonfield et al., The Public Costs of Births Resulting from
Unintended Pregnancies: National and State-Level Estimates, 43 PERSP.
SEXUAL & REPROD. HEALTH 94, 98–99 (2011).
53
Policy Brief: Key Points about Contraception, BRIEFLY (Nat’l Campaign
to Prevent Teen & Unplanned Pregnancy, Washington, D.C.), Sept. 2012, at 1,
2,
available
at
http://www.thenationalcampaign.org/resources/pdf/
Briefly_PolicyBrief_FactsAboutContraception.pdf.
54
Id.
55
See Gorette Amaral et al., Public Savings from the Prevention of
Unintended Pregnancy: A Cost Analysis of Family Planning Services in
California, 42 HEALTH SERVICES RES. 1960 (2007).
56
Id. at 1962, 1970.
57
Tara Parker-Pope, Too Much Medical Care?, N.Y. TIMES WELL BLOG
(July 25, 2012, 12:20 PM), http://well.blogs.nytimes.com/2012/07/25/too-muchmedical-care.
58
Trussell et al., supra note 2, at 1095.
52
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combination pill and not a progestin-only pill,59 a breast exam
would be the sole physical examination relevant to
contraindications of progestin-only pills.60 The American Cancer
Society recommends that the average woman under forty years old
have a clinical breast exam only every three years.61 Additionally,
pap smears are now recommended only every three years by the
American Congress of Obstetricians and Gynecologists.62
Therefore, some women may be forced to undergo unnecessary
screenings during at least some of their annual exams simply to
obtain a prescription for a birth control pill. Allowing women to
forgo unnecessary doctor’s appointments, pelvic exams, and other
screenings that are conducted before a woman can obtain a
prescription for birth control would significantly reduce medical
costs.63 Eliminating the prescription requirement for at least some
types of oral contraceptives, such as a progestin-only pill, could
reduce total expenditures related to unnecessary medical care.64
Nonuse and gaps in contraceptive use, particularly those gaps
resulting from lapses in birth control prescriptions, are among the
primary causes of unintended pregnancies.65 Indeed, though only
59

Daniel Grossman, Oral Contraceptives and Conditions of Safe Over-theCounter Use, OCS OTC WORKING GRP. (Mar. 23, 2012) [hereinafter
Grossman, Oral Contraceptives], available at http://ocsotc.org/wpcontent/uploads/2012/03/Grossman-OTC-public-hearing-presentation-23-Mar12.pdf.
60
See Trussell et al., supra note 2, at 1095.
61
American Cancer Society Guidelines for the Early Detection of Cancer,
AM.
CANCER
SOC’Y,
http://www.cancer.org/healthy/findcancerearly/
cancerscreeningguidelines/american-cancer-society-guidelines-for-the-earlydetection-of-cancer (last modified May 3, 2013).
62
Announcement, New Cervical Cancer Screening Recommendations from
the U.S. Preventative Services Task Force and the American Cancer
Society/American Society for Colposcopy and Cervical Pathology/American
Society for Clinical Pathology, Am. Cong. of Obstetricians & Gynecologists
(Mar.
14,
2012),
http://www.acog.org/About_ACOG/Announcements/
New_Cervical_Cancer_Screening_Recommendations.aspx [hereinafter New
Cervical Cancer Screening Recommendations].
63
See Stephanie Mencimer, Holding Birth Control Hostage, MOTHER
JONES (Apr. 30, 2012), http://www.motherjones.com/politics/2012/04/
doctors-holding-birth-control-hostage.
64
Id.
65
See FDA Public Hearing 2012, supra note 27, at 47.

JOURNAL OF LAW AND POLICY

404

sixteen percent of women who are at risk of experiencing an
unintended pregnancy do not use any form of contraception for a
month or more during the year, these women account for fifty-two
percent of all unintended pregnancies.66
B. Prescription Requirement as a Barrier to Access
The birth control pill is the most popular method of hormonal
contraception.67 However, there are barriers that prevent many
women, especially minority, young, and low-income women—
groups with the highest rates of unplanned pregnancies—from
obtaining the pill.68 A number of women report difficulty accessing
or using methods of birth control as a reason for their nonuse.69
Access issues vary greatly among women.70 For example,
uninsured and low-income women may find it difficult to afford a
visit to a primary care physician and in turn, be unable to obtain a
prescription for a birth control pill.71 In one national survey,
women who used or wanted to use a prescription contraceptive
cited the long wait to get a doctor’s appointment, inconvenient
office hours, the high cost of seeing a physician, and the pelvic
exam requirement—which incidentally does not screen for
contraindications to the pill72—as top obstacles in accessing
66

Facts on Unintended Pregnancy, supra note 40, at 4.
Daniel Grossman, Should the Contraceptive Pill Be Available Without
Prescription?, 338 BRIT. MED. J., Jan. 24, 2009, at 202, 202 [hereinafter
Grossman, Contraceptive Pill].
68
See FDA Public Hearing 2012, supra note 27, at 41–42; Barriers to
Contraceptive Access for Low-Income Women, QUICK SHEET (Nat’l Inst. for
Reprod. Health, New York, N.Y.) [hereinafter Barriers to Contraceptive
Access],
available
at
http://www.nirhealth.org/sections/publications/
documents/contraceptiveaccessquicksheetFINAL.pdf.
69
Jennifer J. Frost et al., Improving Contraceptive Use in
the United States, IN BRIEF (Guttmacher Inst., New York, N.Y.),
Apr. 2008, at 3, available at http://www.guttmacher.org/pubs/2008/05/09/
ImprovingContraceptiveUse.pdf.
70
See Barriers to Contraceptive Access, supra note 68.
71
Id.
72
Felicia H. Stewart et al., Clinical Breast and Pelvic Examination
Requirements for Hormonal Contraception: Current Practice vs. Evidence, 285
J. AM. MED. ASSOC. 2232, 2232 (2001).
67
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prescription oral contraceptives.73 In the same survey, forty-one
percent of nonusers indicated that they would be more likely to use
a patch, vaginal insert, or the pill if it were available without a
prescription.74 One reason for this may be that young women are
concerned about their parents becoming aware of their use of
contraception through the insurers’ billing practices.75 This
concern may affect not only teens, but also young adult women
given that individuals up to age twenty-six may remain on their
parents’ insurance plans.76 Based on the plethora of barriers to
contraceptive access and the privacy issues involved, it is not
surprising that young women, uninsured women, and current oral
contraceptive users alike have a strong interest in an over-thecounter oral contraceptive.77
Federally mandated contraceptive coverage without copayments through the Patient Protection and Affordable Care Act
(PPACA) fails to address all the barriers to access that women may
face. Many barriers, as discussed above, are not directly associated
with cost.78 Moreover, some women will not be covered under the
PPACA, including those women who are undocumented
immigrants, and women whose insurance plans will be
grandfathered into the new system and will be exempt from the
contraceptive coverage mandate.79 Moreover, churches and places
of worship with religious objections are exempt from the
contraceptive mandate and are thus not required to pay for their
73
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female employees’ birth control prescriptions.80
Because PPACA eliminates the cost barrier for a significant
number of women, ensuring that oral contraceptive costs are kept
low if they are indeed switched to over-the-counter status is
extremely important to ensure increased access to the pill.81
Though PPACA only requires coverage for prescription
contraceptives, eliminating the prescription requirement would
save women the cost of doctor’s visits, save time, and increase
convenience in obtaining oral contraceptives.82 Additionally,
commentators have argued that insurance companies should be
required to provide coverage for Plan B, over-the-counter
emergency contraception.83 This coverage, they argue, would
allow women who are unable to afford the over-the-counter retail
price of Plan B to obtain the time-sensitive emergency
contraceptive sooner because they would no longer need a
prescription simply to get insurance coverage.84 Similar requests
for insurance coverage would likely be made when a daily birth
control pill is available over the counter. Even if insurance is not
required to cover an over-the-counter pill, the elimination of the
prescription requirement allows women to choose to pay for the
pill out-of-pocket in order to save the time and expense associated
with a doctor’s visit.85 Thus, although PPACA lowers the cost of
contraceptives for a significant number of American women,
eliminating the prescription requirement for progestin-only pills is
necessary to give women more options for obtaining birth control.
Further, an over-the-counter option for birth control pills would
address the non-monetary barriers associated with oral
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contraceptive access.86
C. A Progestin-Only Pill Could Be Safely Dispensed Over the
Counter Using New Technology
In 1960, the FDA approved the birth control pill for
contraceptive use.87 Since then, it has generally been regarded as
very safe.88 Based on its lower prevalence of contraindications, a
progestin-only pill, as opposed to an estrogen-progestin
combination pill, is the most likely candidate for initial over-thecounter approval.89 Progestin-only oral contraceptives are ninetysix percent effective at preventing pregnancy and work by
thickening the mucus around a woman’s womb while
simultaneously thinning the womb’s lining.90 This makes it
difficult for sperm to enter and for an egg to attach to the lining.91
Progestin-only pills sometimes prevent the release of an egg
altogether, much like an estrogen-progestin combination oral
contraceptive.92 Though perhaps slightly less effective at
preventing pregnancy than estrogen-progestin combination pills,
progestin-only pills are safer for smokers, individuals with high
blood pressure, those prone to clotting abnormalities, and women
who have a family history of heart attack or stroke.93 Indeed,
Hamburg approved an emergency contraceptive pill containing the
progestin levonorgestrel for over-the-counter sale without age or
86
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point of sale restrictions.94 Levonorgestrel is also used in many
daily progestin-only oral contraceptives.95
Besides preventing pregnancy, progestin-only birth control
pills also have health benefits.96 Extensive research indicates that
the progestin-only birth control pill regulates the menstrual cycle,
lowers the risk of anemia, and decreases the “risk of endometrial
cancer and pelvic inflammatory disease.”97 In addition to improved
physical health, women may benefit from using birth control in
other ways.98 A University of Michigan study, though not specific
to progestin-only pills, found that women who begin taking
hormonal birth control pills at an early age are more likely to have
higher paying careers later in their lives than women who begin
taking the pill at an older age.99 The reason, according to the study,
is that “[a]s the Pill provided women with cheaper and more
effective control over childbearing in late adolescence, they
invested more in their human capital and careers.”100
Several studies have shown that women are able to take a daily
birth control pill safely without physician involvement.101 In
determining whether to write a prescription for an oral
contraceptive, a physician relies mostly on a patient’s medical
history.102 Unsurprisingly, research shows that women who
obtained oral contraception after a doctor’s visit were no less likely
to have contraindications to the pill than those women who
obtained the pill directly from a pharmacy.103 In a study examining
94
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women’s continued use of oral contraceptives, discontinuing the
pill was more common among women who obtained the
contraceptive via a doctor’s prescription than those who acquired
the pill over the counter.104 The findings, the researchers suggest,
indicate that “removing the prescription requirement for [oral
contraceptive pills (OCPs)], in addition to making it easier for
women to initiate OCP use, would not have an adverse impact on
continuation and might well improve it.”105
Emerging technology could be used to increase access to the
pill and improve efficiency in dispensing an oral contraceptive
over the counter.106 At the FDA’s 2012 public hearing, Elizabeth
Dawes, a senior associate with the non-profit Reproductive Health
Technologies Project, explained that technology could improve the
distribution of oral contraceptives.107 According to Dawes, the
improved efficiency will be necessary given that more individuals
will likely seek medical care after receiving insurance coverage
through PPACA.108 During her presentation, Dawes described new
technology such as “electronic kiosks, retail clinics, and selfdispensing machines” that are currently being developed to
dispense contraceptives.109 She explained that research shows these
methods of access “to be acceptable and appropriate for clients
willing to forego an in-person consultation with the clinical
provider.”110 Dawes even said that for patients who would like
professional guidance in their decision to use oral contraceptives,
technology could be used to increase convenience.111 As Dawes
the pill over-the-counter are no more likely to experience side effects than
women who had a doctor’s appointment before using the pill. Id. at 202.
104
Joseph E. Potter et al., Continuation of Prescribed Compared With
Over-the-Counter Oral Contraceptives, 117 OBSTETRICS & GYNECOLOGY 551,
551 (2011). The study compared 514 women who obtained over-the-counter
pills in Mexico and 532 women who obtained prescription birth control pills in
El Paso, Texas. Id.
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asserted, the “expanded use of telephone or provider-to-patient
video interface” has been shown to be effective at producing both
patient satisfaction and positive health outcomes while
simultaneously lowering the cost of health care.112
This type of technology could improve the safe distribution of
an over-the-counter birth control pill.113 Dr. Eleanor Schwarz, the
Director of Women’s Health Research for the Center for Research
on Health Care at the University of Pittsburgh, presented at the
same hearing.114 Schwarz described a study in which computerized
kiosks were programmed to screen for all of the World Health
Organization’s identified contraindications to birth control pills
containing estrogen.115 The kiosk featured text in both English and
Spanish and provided an audio option for individuals with
restricted literacy.116 The kiosk provided information about seven
methods of contraception and women, after learning about these
methods, had the option to request a prescription.117 Upon this
request, the kiosk asked women questions designed to screen them
for contraindications to the method they had selected.118 If the
kiosk determined that the method was safe for the particular
woman, it printed a prescription, which also included the screening
information.119 The patient then gave this information to a health
care provider who would fill the prescription after checking the
patient’s blood pressure.120
Most women who used the kiosk had a positive experience
with the system.121 Women who used the kiosk reported that it
provided them with trustworthy information and was easy to
112
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See id. at 47.
114
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understand and use.122 The success of the kiosk system led
Schwarz and her team to conduct additional research.123 Using a
sample of more than 800 women in four different health care
settings, half were randomly assigned to the contraceptive kiosk.124
Minority women, women with low levels of education, and women
who hadn’t used a method of contraception during their last
intercourse—groups with high rates of unintended pregnancies—
were especially likely to seek prescriptions after using the
kiosks.125
As indicated by extensive research and the low prevalence of
contraindications, progestin-only oral contraceptives are generally
accepted as safe.126 Indeed, as discussed above, a progestin-only
pill, albeit an emergency contraceptive variety, is already available
over the counter.127 Further, because physicians heavily rely on the
medical history provided by the patient herself in determining
whether or not to prescribe a progestin-only birth control pill, a
doctor’s involvement in a woman’s decision to use this method of
oral contraception is generally unnecessary.128 Technology that is
in development or already available could be used to aid in the
efficient and safe distribution of a daily progestin-only pill.129
Though the kiosk system described above would be expensive to
install widely, it provides an example of how emerging technology
could work to carefully dispense an already safe drug to those who
need it. The FDA typically uses labeling to safely distribute overthe-counter drugs,130 and the same would certainly be done for a
122
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birth control pill when it is made available over the counter.
Therefore, whether it be through a high-tech kiosk or the FDA’s
more traditional labeling approach, a progestin-only oral
contraceptive could be safely dispensed over the counter.
II. THE FDA AND CRITERIA
COUNTER SWITCH

FOR A

PRESCRIPTION

TO

OVER-THE-

On June 30, 1906, Congress passed the Food and Drug Act.131
Approved by President Theodore Roosevelt, the Act banned states
from buying or selling mislabeled or tainted drugs, food, and
drinks.132 The Federal Food, Drug, and Cosmetic Act (FDCA),
passed in 1938, required that new drugs meet a threshold level of
safety before they were approved by the FDA.133 In 1951, the
Durham-Humphrey Amendment to the FDCA required that any
“habit-forming or potentially harmful [drug] . . . be dispensed
under the supervision of a health practitioner as a prescription
drug.”134
The FDA is permitted to exempt drugs from the prescription
requirement when the Agency determines that such a requirement
is “not necessary for the protection of the public health.”135 Drugs
can be fully or partially switched from prescription to over the
counter status or a new drug can be directly classified as over the
counter.136 Because the FDA has not set forth a rigid test to
any age or point-of-sale restrictions, even though they are unsafe for
unsupervised use by young adolescents, stands in stark contrast to its refusal to
make equally available concededly safe and time-sensitive levonorgestrel-based
emergency contraceptives.”).
131
History of the FDA and Drug Regulation in the United States, FDA, at
1, available at http://www.fda.gov/downloads/Drugs/ResourcesForYou/
Consumers/BuyingUsingMedicineSafely/UnderstandingOver-theCounterMedicines/ucm093550.pdf.
132
Id.
133
Id. at 2.
134
This Week in FDA History - Oct. 26, 1951, FDA,
http://www.fda.gov/AboutFDA/WhatWeDo/History/ThisWeek/ucm117875.htm
(last updated May 20, 2009).
135
21 U.S.C. § 353 (2012).
136
Regulation of Nonprescription Drug Products, FDA, available at
http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM148055.
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determine whether a prescription drug should be made available
over the counter, drugs are made available without a prescription
on an ad hoc basis.137 There are, however, several criteria that are
traditionally applied in making such a determination.138 Factors
used in the FDA’s determination include: (1) whether or not the
drug has significant toxicity in the event of an overdose, (2)
whether the drug is addictive, (3) whether users are able to “selfdiagnose conditions for appropriate use,” (4) whether users are
able to take the medication safely without a medical professional’s
screening, and (5) whether users are able to take the drug as
directed without the explanation of a healthcare provider.139
Progestin-only birth control pills easily satisfy the first three
factors. Birth control pills are not significantly toxic in the event of
an overdose, are not addictive,140 and, as previously discussed,
women are able to self-diagnose their own need to use oral
contraception.141 Research indicates that the remaining two factors
could also be satisfied.142 Recent studies and events illustrate that
women can safely use progestin-only contraceptives without a
doctor’s screening. This is evidenced by the availability of
technology that could be used to screen for contraindications and
studies that reveal that women obtaining progestin-only pills over
the counter are no more likely to experience adverse reactions than
women who obtained the contraceptive with a prescription.143 The
final factor, the ability to take medicine without the explanation of
a healthcare provider, could be met with clear and informative
labeling as well as with new technology such as the kiosks
discussed above.144 Therefore, a progestin-only birth control pill
can effectively meet each of the factors the FDA considers in
pdf.
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determining whether a drug should be made available over the
counter.
III. POTENTIAL
CONSTITUTIONAL
CHALLENGES
TO
THE
PRESCRIPTION REQUIREMENT FOR A PROGESTIN-ONLY BIRTH
CONTROL PILL
In order to consider potential constitutional claims, several
requirements with regard to procedure must first be met. The first
requirement is that the FDA Commissioner puts forth an
exemption proposal, a drug sponsor files the requisite
supplemental drug application, or a citizen group submits a petition
to switch a progestin-only oral contraceptive from prescription to
over-the-counter status.145 Second, the FDA’s decision to deny
such a proposal or application must constitute a final agency
action.146 If these requirements were met, the FDA action would be
subject to judicial review. The plaintiffs’ hypothetical
constitutional claim would not be reviewed under the same
standard used in Hamburg, the arbitrary and capricious standard.147
Because the claim would be a constitutional one, not merely one
challenging an agency action as was the case in Hamburg, the less
agency-deferential de novo review would be applicable to
plaintiffs’ claim.148
The FDA’s decision to reject a petition allowing over-thecounter emergency contraception, as discussed in Hamburg, may
forecast its future actions with respect to a daily birth control
pill.149 The FDA may again deviate from policy to deny a petition
145
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as it did for emergency contraception. Such actions by the FDA
would be highly scrutinized in a hypothetical case.150 In Hamburg,
Judge Korman mentioned that because “the constitutional right to
obtain and use contraceptives” was implicated by the restriction on
the sale of Plan B, “an even more careful examination of [the
unprecedented intervention of the HHS Secretary]” was
justified.151 Indeed, a constitutional claim invoking the right to
contraception would be a next logical step for reproductive rights
advocates in light of Hamburg. In Hamburg, plaintiffs were
successful because the FDA’s actions were deemed arbitrary and
capricious.152 In the context of a daily pill, plaintiffs alleging a
constitutional claim would enjoy a stricter standard, though any
similar arbitrary and capricious FDA actions would lend support to
the constitutional claim.153 Assuming the above procedural
requirements were satisfied, any decision by the FDA to deny a
petition or application for an over-the-counter daily birth control
pill, particularly after Hamburg, has the potential to generate a
viable constitutional claim.
A. Fifth Amendment Substantive Due Process
Advocates for an over-the-counter progestin-only birth control
pill may choose to allege a government violation of the Fifth
Amendment’s substantive due process guarantee. Under this
framework, plaintiffs would need to first assert government
infringement on a fundamental right.154 If the right is deemed
fundamental, the government then bears the burden to show that
the prescription requirement for a progestin-only oral contraceptive
is supported by a compelling interest.155 Additionally, the
FDA.”).
150
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government must show that the prescription requirement for a
progestin-only oral contraceptive is narrowly tailored to serve that
articulated compelling interest.156
Plaintiffs could argue that the fundamental right to privacy is
implicated in the prescription requirement for a daily progestinonly birth control pill. The U.S. Supreme Court’s decisions in
Griswold v. Connecticut,157 Eisenstadt v. Baird,158 and Carey v.
Population Services International159 support the assertion that a
fundamental right is at issue.160 Griswold classified the right to
contraception as a right imbedded in the right to privacy by
reasoning that, among married couples, the decision to use
contraceptives fell within a zone of privacy. 161 Afterwards,
Eisenstadt and Carey expanded and clarified the right to
contraception.162 In Eisenstadt, the Court extended the right to use
contraception, encompassed in the right to privacy, to unmarried
people using an equal protection analysis.163 In doing so, the Court
re-characterized the right to contraception as a right to procreative
privacy, rather than simply a right to marital privacy as described
in Griswold.164 In Eisenstadt, the Court reasoned that, “[i]f the
right to privacy means anything, it is the right of the individual,
married or single, to be free of unwarranted governmental intrusion
into matters so fundamentally affecting a person as the decision
whether to bear or beget a child.”165 Though it could be argued that
the right to contraception imbedded in the fundamental right to
privacy does not necessarily indicate that there is a right to access
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contraception, the Court’s decision in Carey is telling.166 There, the
Court decided that a law limiting the display, advertisement, and
distribution of contraceptives was unconstitutional and held that
government restrictions on contraceptive access must meet strict
scrutiny.167 The Court reasoned that “[t]his is so not because there
is an independent fundamental ‘right of access to contraceptives,’
but because such access is essential to exercise of the
constitutionally protected right of decision in matters of
childbearing.”168 Following this line of cases, the Court appears
willing to include the right to use contraception “free from
“unjustified intrusion by the state”169 as part of the right to privacy.
Roe v. Wade170 and Planned Parenthood v. Casey171 also
provide guidance in this analysis and suggest that a fundamental
right is implicated in the prescription requirement for a progestinonly birth control pill. Both cases, though relating to abortion
rights, suggest that women have fundamental rights concerning
their reproductive decisions.172 In Roe, the Court determined that
the “right of privacy . . . is broad enough to encompass a woman’s
decision whether or not to terminate her pregnancy.”173 It follows
that a woman’s decision whether or not to prevent pregnancy in the
first place is also a fundamental right encompassed in the right to
privacy.174 In Casey, the Court recognized that “choices central to
dignity and autonomy are central to the liberty [protected by the
Constitution]” and asserted that, “[a]t the heart of liberty is the
right to define one’s own concept of existence, of meaning, of the
166

See Carey, 431 U.S. at 697–98.
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universe, and of the mystery of human life.”175 Though Roe and
Casey concern abortion rights, the reasoning used in both cases is
applicable to the right to contraception as fundamental under the
right to privacy: women have the right to control their reproduction
and make autonomous decisions in these matters.176
The rights to contraceptive access, autonomy, and personal
dignity have been expressly articulated by the Court.177 Plaintiffs
challenging the prescription requirement using the Fifth
Amendment’s substantive due process guarantee should be able to
articulate a fundamental right at issue. After plaintiffs assert that
the prescription requirement for a progestin-only oral contraceptive
implicates the fundamental right to privacy and imbedded right to
contraception, the burden would then shift to the government.178
The government must show a compelling interest behind the
prescription requirement and subsequently show that the regulation
was narrowly tailored to serve that compelling interest.179
The FDA would most likely assert that the prescription
requirement serves the government’s compelling interest in
protecting women’s health.180 Roe established that “the State [has]
an important and legitimate interest in preserving and protecting
the health of the pregnant woman . . . and that it has
still another important and legitimate interest in protecting the
potentiality of human life.”181 It is likely that the government’s
interest in protecting women’s health would be found to be
sufficiently compelling and would thus satisfy the first prong.182
175
176
177
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If a court determined that the government had a compelling
interest in women’s health, the FDA would have the burden to
show that the prescription requirement for progestin-only oral
contraceptives was narrowly tailored to serve that interest.183 The
government would be unable to show that the prescription
requirement is narrowly tailored to serve its compelling interest.
The prescription requirement is over-inclusive in that it applies to
all women, rather than exclusively to the small percentage of
women with contraindications to a progestin-only pill.184 For other
drugs, the FDA addresses similar concerns about contraindications
in a small subset of the population through labeling, not by
excluding these drugs from over-the-counter distribution.185
Although women who obtain a prescription for a progestin-only
oral contraceptive would be afforded the opportunity to consult
with their healthcare provider regarding their decision to use this
method of contraception, evidence shows that technology within
pharmacies could provide the same level of guidance.186 Women
are able to assess their own need to use oral contraceptives and
regardless of whether women consult with a physician, the daily
administration of the pill is left in their hands. Healthcare providers
determine whether a woman should be prescribed birth control,
especially a progestin-only pill, almost entirely by hearing a
recitation of the woman’s medical history. Women could just as
easily read labels that explain contraindications, as they are asked
to do with other FDA-approved over-the-counter products, and
then make an informed decision about whether or not to take the
The government could use this line of reasoning to argue that the prescription
requirement serves its interest of maintaining such standards by ensuring that
doctors act as gatekeepers to oral contraception that could be dangerous for
some women.
183
See CHEMERINSKY, supra note 154, at 817.
184
“[A] classification that is substantially overinclusive or underinclusive
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legitimate” purposes. Bernal v. Fainter, 467 U.S. 216, 221 (1984) (citation
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185
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pill.187
In addition, emerging technology could improve the safe
distribution of an over-the-counter pill, further undermining the
government’s argument that the prescription requirement is
narrowly tailored to protect women’s health. One example is that
women could use the kiosk system, discussed above in Part I.C., to
input their health histories and undergo screenings for
contraindications as well as subsequently consult with a pharmacist
in the same location where they would obtain the pill. Regarding
these kiosks, clearly and carefully worded questions, a private
comfortable setting, as well as features for non-English speakers
and individuals with limited literacy have the potential to not only
meet, but improve the accuracy and thoroughness of the medical
history information given by a woman seeking oral contraception.
In this manner, emerging technology could be used to provide
convenient and safe access to oral contraceptives.
The prescription requirement for birth control pills ultimately
results in more health risks and poorer health outcomes for women
than they would face in the absence of such a requirement.188 This
is perhaps the strongest argument as to why the prescription
requirement for a progestin-only birth control pill is not narrowly
tailored to serve the government’s interest in protecting women’s
health. As suggested above, there is also substantial evidence to
suggest that oral contraceptives actually improve a woman’s health
by, for example, lowering her risk of contracting endometrial
cancer and pelvic inflammatory disease.189
Aborting a pregnancy or carrying a pregnancy to full term both
pose higher risks for a woman’s health than using oral
contraception.190 Unintended pregnancies, many of which could be
187
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prevented with greater availability of oral contraceptives, are
especially risky for a woman’s health because women experiencing
an unplanned pregnancy are less likely to seek appropriate prenatal
care.191 Also, “[w]omen with unwanted, mistimed, or unplanned
births demonstrate lower levels of general psychological wellbeing during pregnancy and following the birth, and a higher risk
of depression . . . .”192 For children born as a result of these
pregnancies, “unintendedness seems to be most closely associated
with poor physical health, poor mental health, a less close motherchild relationship, and poor educational outcomes.”193 Moreover,
unintended pregnancies resulting in births produce high costs to
society as a whole.194 Considering the possible health benefits of
birth control, the dangers of unplanned pregnancies, and the
emergence of technology to provide safeguards to over-the-counter
distribution, the prescription requirement is not narrowly tailored
to serve the government’s interest in protecting women’s health.
The hypothetical plaintiffs would likely be able to show that
the prescription requirement infringes on the fundamental right to
privacy under the substantive due process guarantee. 195 While the
government would plausibly be able to show a compelling interest
in maintaining the prescription requirement for progestin-only oral
contraceptives, the government could not demonstrate how the
requirement was narrowly tailored to protect women’s health.
Plaintiffs would thus have a viable chance of success in alleging a
Fifth Amendment substantive due process violation present in the
prescription requirement for a progestin-only pill.
B. Classification-Based Equal Protection
A challenge to the prescription requirement for a progestinonly oral contraceptive could also be brought under the equal
Though first trimester abortions pose minimal risks, “[t]he risk of death
associated with abortion increases with the length of pregnancy . . . .” Id.
191
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192
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protection clause of the Fourteenth Amendment.196 Unlike the
substantive due process clause, the equal protection clause does not
create substantive individual rights.197 Rather, the equal protection
clause asks whether the government has a sufficient purpose in
imposing a law that classifies and distinguishes between groups of
people.198 When regulations are facially neutral, as is the case with
the prescription requirement for a progestin-only pill, the plaintiff
must show that the law has both a disparate impact and a
discriminatory purpose.199
1. Gender Classification Claim
In equal protection cases alleging classification based on
gender, intermediate scrutiny200 is used.201 Under intermediate
scrutiny, if the law at issue is facially neutral as is the prescription
requirement, the plaintiffs must articulate that the law is
purposively discriminatory and that the law has a discriminatory
effect on males or females.202 Then, the burden shifts to the
government to show that the regulation at issue is “substantially
related to serving an important government purpose.”203
The prescription requirement is facially neutral because it does
not explicitly classify men and women. Therefore, plaintiffs have
the burden of showing both that the prescription requirement has a
disparate impact on women, and there is a discriminatory purpose
196
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behind it.204 The disparate impact of the prescription requirement is
evident: only women use oral contraception and therefore are the
only sex subjected to the prescription requirement.
Plaintiffs also have a strong argument that there is a
discriminatory purpose behind the prescription requirement. In
Village of Arlington Heights v. Metropolitan Housing Development
Corp.,205 the Court identified different ways plaintiffs could
demonstrate a discriminatory purpose.206 A discriminatory purpose
can be shown by a historical pattern of discrimination, statistical
patterns that can only be explained by discrimination, and
legislative or administrative history that points toward
discrimination.207 Here, plaintiffs have a number of arguments at
their disposal. First, plaintiffs could point to the historical
discrimination of women in general. Additionally, plaintiffs could
cite reports showing that virtually every part of the required
doctor’s visit in order to obtain a prescription is unnecessary to
determine whether a progestin-only birth control pill would be safe
for use.208 Plaintiffs could also reference statistics that women
could easily use available technology and informative labeling to
safely take a progestin-only oral contraceptive.209
In proving a discriminatory purpose, plaintiffs can also rely on
evidence that the FDA has a history of discriminating against
women’s rights to access contraception.210 Plaintiffs could
specifically point to the FDA’s unusual action to delay, and
eventually deny, over-the-counter emergency contraception for
females of all ages as evidence of the FDA’s discriminatory
motivation in thwarting attempts to expand the availability of oral
204
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contraceptives.211 In fact, the FDA has a long history of taking
unusual actions to delay and prevent expanded access to oral
contraceptives for women.212 For example, the initial Plan B
prescription to over-the-counter switch application was the only
one of sixty-seven applications filed between 1994 and 2004 not to
be approved after advisory committees recommended approval.213
In Hamburg, Judge Korman identified a plethora of features of
the FDA’s decision-making process that rendered the denial of the
citizen petition unprecedented.214 For example, HHS Secretary
Sebelius cited “cognitive and behavioral differences between older
adolescent girls and the youngest girls of reproductive age” as a
reason to direct the FDA to deny the petition for over-the-counter
access for females of all ages.215 However, normally the FDA does
not rest its decisions about whether to switch a drug from
prescription to over-the-counter on “theoretical abuse by a very
small segment of the population.”216 If the FDA did, then it would
be required to stop selling any “drugs with known abuses” over the
counter, including “laxatives because of abuse by people suffering
from bulimia” and “acetaminophen because of its use in
211
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212
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other aspects of the FDA’s review of the Plan B application to be “unusual.” For
example, “high-level management was more involved in the review of Plan B
than in those of other OTC switch applications” and “there are conflicting
accounts of whether the decision to not approve the application [on May 6,
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suicides.”217 Hypothetical plaintiffs could use this kind of evidence
to show that a discriminatory purpose underlies the prescription
requirement for progestin-only pills. The plaintiffs have support
that the FDA’s “administrative history [is] highly relevant” to a
determination of discriminatory purpose.218
If plaintiffs are successful in proving disparate impact and
purposeful discrimination, then the government must make two
showings. First, the government must show that the prescription
requirement serves an important objective.219 Second, the
government must show that the means of the classification are
substantially related to the achievement of that important
governmental objective.220
The Court’s decision in Cleveland Board of Education v.
LaFleur may be instructive to plaintiffs challenging the
prescription requirement for a progestin-only birth control pill. In
LaFleur, the Court declared that a school board requirement that
pregnant employees take maternity leave at a fixed time in their
pregnancies was unconstitutional.221 The Court reasoned that the
regulation amounted “to a conclusive presumption that every
pregnant teacher who reaches the fifth or sixth month of pregnancy
is physically incapable of continuing” to teach.222 Plaintiffs
challenging the prescription requirement for a progestin-only birth
control pill could make a similar argument that the prescription
requirement does not serve an important governmental interest.
Just as the Cleveland Board of Education’s maternity leave
requirement did not substantially serve its articulated interest,
promoting educator continuity in instruction,223 the prescription
requirement for a progestin-only birth control pill does not
substantially serve the government’s alleged interest in protecting
women’s health. In LaFleur, the Court assumed that all pregnant
teachers are unable to continue working at a board-determined
217
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time in their pregnancy.224 Here, the prescription requirement rests
on an agency-determined assumption that women need an
incentive, in this case a birth control prescription, to seek
preventative medical care.225 Both the requirement in LaFleur and
the prescription requirement for a progestin-only birth control pill
seem to further the belief that agencies and boards understand the
needs and psyche of all women better than an individual woman
can make autonomous decisions in her own health-related matters.
In later cases, the Court clarified its holding in LaFleur. The
Court explained that the government’s “justification must be
genuine, not hypothesized or invented post hoc in response to
litigation. And it must not rely on overbroad generalizations about
the different talents, capacities, or preferences of males and
females.”226 The Court further declared that in classifying on the
basis of sex, the government must demonstrate an “exceedingly
persuasive” justification for the action.227 Even if the government
can pass the high hurdle in asserting an important interest behind
the requirement, the government must still show that the means of
the requirement are substantially related to the achievement of that
interest.228
Using this framework, hypothetical plaintiffs could challenge
the government’s asserted interest in women’s health. Protecting
the health of women was likely the government’s actual objective
in requiring a prescription for progestin-only oral contraception.
However, a mounting body of evidence suggests that a progestinonly pill could be safely dispensed over the counter.229 This
evidence, plaintiffs could assert, suggests that the women’s health
objective may indeed be a post hoc rationalization for maintaining
the prescription requirement when the progestin-only pill has been
considered safe for quite some time.
The government may choose to supplement its articulated
purpose of protecting women’s health. It could assert that the
224
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226
227
228
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prescription requirement gives women a needed incentive to have
regular annual exams, even though these exams have little to do
with a doctor’s determination that a patient can safely take a
progestin-only pill.230 However, the U.S. Preventative Services
Task Force and the American Cancer Society now discourage
annual pap tests in favor of less frequent tests depending on a
woman’s age, risk factors, and prior screening results.231 Though it
might in fact be the case that women who would otherwise forgo
annual exams submit to them in order to obtain a birth control
prescription, this paternalistic rationalization cannot meet the
government’s burden.
The government may also rely on an “overbroad
generalization” by assuming that all women desire direct
communication with their doctor, a physical examination, and
prescription before choosing to use oral contraception.232 Evidence
suggests that given the inconvenience and expense of doctor’s
visits, coupled with women’s ability to use emerging technology to
safely make a decision, many women would prefer an over-thecounter birth control pill.233 Thus, though the government’s
objective of protecting women’s health is indeed important, the
government would likely be unable to provide the required
“exceedingly persuasive justification”234 for the prescription
requirement.
Even if the government did have a sufficiently important
interest in protecting women’s health, its means are not
substantially related to that interest. As discussed above, the
barriers the prescription requirement generates actually pose health
risks to women.235 Oral contraceptives have numerous health
benefits and unintended pregnancies can pose serious health risks
for both the mother and child.236 There is indeed an alternative to
the current oral contraceptive prescription regime that would
230
231
232
233
234
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enable greater access to birth control for women while ensuring
their safety.237 As explained above, estrogen-progestin
combination pills have more contraindications than progestin-only
contraceptives.238 By maintaining the prescription requirement for
estrogen-progestin pills while making a progestin-only pill
available over the counter, women would no longer be subjected to
unnecessary paternalistic barriers hindering access to oral
contraception.
Thus, plaintiffs would likely be able to show that the facially
neutral prescription requirement has both a discriminatory impact
on women and is purposively discriminatory. The government may
have difficulty showing that its interest in women’s health is not a
post hoc rationalization for the maintenance of the prescription
requirement and that the requirement is not based on overbroad
generalizations. However, the government may be able to meet the
first of its burdens to show that there is an important interest—the
protection of women’s health—behind the prescription
requirement. However, the government would likely be unable to
show that the prescription requirement substantially serves its
interest in women’s health. Plaintiffs may therefore have success in
pursuing a gender classification-based equal protection violation
claim.
2. Other Classification-Based Equal Protection Claims
As discussed above, access issues imposed by the prescription
requirement
for
progestin-only
oral
contraceptives
disproportionately affect minority women, young women, and lowincome women as evidenced by the high instances of unintended
pregnancies among these groups.239 Plaintiffs may therefore
choose to challenge other classifications imposed by the
prescription requirement. Because the prescription requirement is
facially neutral, to allege an impermissible classification based on
race or national origin, plaintiffs would have to make two
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showings to subject the classification to heightened scrutiny.240
First, they would need to show that the prescription requirement
has a disproportionate impact on a racial or ethnic group. Second,
plaintiffs would need to show the there is a discriminatory purpose
underlying the prescription requirement.241 Any wealth and age
classification claims brought by the plaintiffs challenging the
prescription requirement would be subject only to rational basis
review.242
In regards to race, national origin, and alienage, plaintiffs could
likely show the disparate impact of the prescription requirement.
They could assert, for example, that African-American women
experience significantly more unintended pregnancies than any
other racial group in the country and are more likely than white
women to have gaps in contraceptive use.243 Though they may
meet the requirements for disparate impact, plaintiffs would be
challenged to show that there is a racially discriminatory purpose
behind the prescription requirement. In Washington v. Davis,244 the
Court upheld a police officer promotion test that had a higher
passage rate among white employees than black employees. The
Court reasoned that without evidence of a discriminatory purpose,
a regulation that disparately impacts a racial group will be subject
only to rational basis review.245 Unlike a potential gender
classification claim where the requirement applied only to women,
240
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and not men, the prescription requirement applies to women of all
races. Therefore, the government would be able to show that it
would have imposed the same requirement without the alleged
impermissible racial purpose.246
Because plaintiffs could not produce sufficient evidence of a
discriminatory purpose related to race or national origin and the
Court has expressly articulated that wealth and age classifications
are subject only to rational basis review, claims based on race,
national origin, alienage, wealth, or age would not be subject to
heightened scrutiny.247 The prescription requirement would be
upheld under rational basis review since the government would be
able to show that protecting women’s health is, in fact, a legitimate
purpose and that the requirements had a rational relation to that
legitimate government purpose.248 Because the prescription
requirement allows doctors to make the determination about
whether an oral contraceptive would be safe for an individual
patient, a court would likely hold that the prescription requirement
for a progestin-only birth control pill is rationally related to
protecting women’s health. Such a holding would occur despite the
fact that the prescription requirement is over-inclusive and that the
women’s health objective may not be the actual purpose in the
long-time maintenance of the prescription requirement for
progestin-only oral contraceptives. Therefore, in bringing an equal
protection violation claim, plaintiffs would only have a viable
chance of success in asserting an impermissible classification on
the basis of gender.
CONCLUSION
The prevalence of unintended pregnancies and the negative
consequences that accompany these pregnancies necessitates
efforts to reduce barriers to contraceptive access.249 Though oral
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contraceptives are one of the most effective and widely used
contraceptive methods, the prescription requirement makes the
process of obtaining birth control pills unnecessarily difficult.250
As evidenced by the over-the-counter approval process the FDA
employed for Plan B emergency contraception, the FDA will likely
continue its practices of delaying and denying expanded access to
oral contraception.251 Indeed, the politics surrounding birth control,
rather than the health risks associated with such drugs, prevents
women from exercising their full constitutional right to use
contraception.
Thus, plaintiffs would be able to make a strong showing that
the prescription requirement for progestin-only oral contraceptives
is in fact unconstitutional. Though the right to contraception has
been recognized since the 1960s, increased safety, improved
technology, and the known health benefits of oral contraceptives
have not been adequately considered to fully realize the benefits of
contraceptive use in today’s society.252 The prescription
requirement for a progestin-only oral contraceptive indicates that
our nation’s long history of female subordination and paternalism
of women has not been wholly abolished.253 The elimination of the
prescription requirement would therefore serve the goals of gender
equality and a full recognition of the modern right to
contraception. It would also address the prevalence of unintended
pregnancies and the negative implications of these pregnancies on
women, children, and society as a whole.254 Safety concerns,
politics, and paternalistic rationales supporting the maintenance of
the prescription requirement for the pill are facing ever-growing
scrutiny by the courts, medical associations, and by the public at
large. Eliminating the prescription requirement for a progestin-only
oral contraceptive would give women the ability to more fully
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250
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control their own birth control decisions.

